|
⚲
|
| Keyboard |
| McIntosh David M
✚
|
|
|---|---|
| CIK # | 0001317248 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001317248] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McIntosh David M | |
| Rexahn Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rexahn Pharmaceuticals Inc RNN
Stock Option (right to buy) · derivative
|
2014-06-09 | Grant | 60,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Common Stock
|
2014-04-14 | Tax withheld | 99,010 | $1.01 | 100,000 |
|
Rexahn Pharmaceuticals Inc RNN
Common Stock
|
2014-04-14 | Option exercise | 125,000 | $0.80 | 100,000 |
|
Rexahn Pharmaceuticals Inc RNN
Stock Options (right-to-buy) · derivative
|
2014-04-14 | Option exercise | 125,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Stock Options (right-to-buy) · derivative
|
2013-06-11 | Grant | 60,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc RNN
Stock Options (right-to-buy) · derivative
|
2012-06-18 | Grant | 20,000 | $0.00 |